When it comes to ILC2, recent evidence showed that murine ILC2 could produce VEGF-A in asthmatic inflammation (147), but there is no evidence that this ILC2 pro-angiogenic function could be observed in cancer. The gene discussed is VEGFA; the disease is cancer.